ZA 66 125 mg (Divalproex sodium (sprinkle) 125 mg)

Pill imprint ZA 66 125 mg has been identified as Divalproex sodium (sprinkle) 125 mg.

Divalproex sodium is used in the treatment of bipolar disorder; migraine prevention; mania; epilepsy; hyperekplexia (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for ZA 66 125 mg (Divalproex sodium (sprinkle) 125 mg)

Divalproex sodium (sprinkle) 125 mg ZA 66 125 mg
Divalproex sodium (sprinkle)
ZA 66
125 mg
125 mg
Blue & White
22.00 mm
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
N - Not a controlled drug
Zydus Pharmaceuticals
National Drug Code (NDC):
Inactive Ingredients:
FD&C Blue No. 1
silicon dioxide
triethyl citrate
methacrylic acid
sodium lauryl sulfate
magnesium silicate
titanium dioxide
microcrystalline cellulose
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0313 Amerisource Health Services

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)